Management of CMV retinitis in HIV infected patients.

by Katlama, C
Published 1997

Immune Suppression as the Etiology of Failure To Detect Anti-HBc Antibodies in Patients with Chronic Hepatitis B Virus Infection

by Avettand-Fenoel, V., Thabut, D., Katlama, C., Poynard, T., Thibault, V.
Published 2006

T cell receptor gamma/delta+ lymphocyte subsets during HIV infection.

by Autran, B, Triebel, F, Katlama, C, Rozenbaum, W, Hercend, T, Debre, P
Published 1989

Relapses of CMV retinitis after 2 years of highly active antiretroviral therapy

by CASSOUX, N, BODAGHI, B, FILLET, A, CARCELAIN, G, KATLAMA, C, LEHOANG, P
Published 2000

Distribution, characteristics, and prognostic of AIDS and non-AIDS cancers in HIV-infected patients, the ONCOVIH study

by Lanoy, E, Spano, JP, Bonnet, F, Boué, F, Katlama, C, Costagliola, D
Published in Infect Agent Cancer (2009)

Cystoid macular oedema and cytomegalovirus retinitis in patients with HIV disease treated with highly active antiretroviral therapy

by Cassoux, N., Lumbroso, L., Bodaghi, B., Zazoun, L., Katlama, C., LeHoang, P.
Published 1999

Mycobacterium simiae and Mycobacterium avium-M. intracellulare mixed infection in acquired immune deficiency syndrome.

by Lévy-Frébault, V, Pangon, B, Buré, A, Katlama, C, Marche, C, David, H L
Published 1987

Virological diagnosis of progressive multifocal leukoencephalopathy: detection of JC virus DNA in cerebrospinal fluid and brain tissue of AIDS patients.

by Moret, H, Guichard, M, Matheron, S, Katlama, C, Sazdovitch, V, Huraux, J M, Ingrand, D
Published 1993

Epidemiology of cryptosporidiosis among European AIDS patients.

by Pedersen, C, Danner, S, Lazzarin, A, Glauser, M P, Weber, R, Katlama, C, Barton, S E, Lundgren, J D
Published 1996

Early Detection of Hepatitis C Virus Infection by Use of a New Combined Antigen-Antibody Detection Assay: Potential Use for High-Risk Individuals

by Schnuriger, A., Dominguez, S., Valantin, M.-A., Tubiana, R., Duvivier, C., Ghosn, J., Simon, A., Katlama, C., Thibault, V.
Published 2006

Description clinique et diagnostique sérologique des patients présentant des symptômes persistants après suspicion d’infection à SARS-COV-2

by Seang, S., Ktorza, N., Monsel, G., Abdi, B., Marcelin, A., Valantin, M., Pourcher, V., Caumes, E., Katlama, C., Tubiana, R.
Published in Med Mal Infect (2020)

Pharmacokinetics of foscarnet after twice-daily administrations for treatment of cytomegalovirus disease in AIDS patients.

by Taburet, A M, Katlama, C, Blanshard, C, Zorza, G, Gazzard, D, Dohin, E, Gazzard, B G, Frostegard, C, Singlas, E
Published 1992

Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy

by Martinez, V, Caumes, E, Gambotti, L, Ittah, H, Morini, J-P, Deleuze, J, Gorin, I, Katlama, C, Bricaire, F, Dupin, N
Published 2006

Week 48 efficacy of 900/100 mg daily of darunavir/ritonavir in treatment-experienced HIV-1 patients with virological success: DARDAR study

by Schneider, L, Houssaini, A, Lambert, S, Peytavin, G, Agher, R, Chermak, A, Flandre, P, Calvez, V, Marcelin, AG, Ghosn, J, Katlama, C
Published 2010

COVIDOM : une expérience de télémédecine unique pour la gestion du COVID-19

by Dinh, A., Bleibtreu, A., Deconinck, L., Katlama, C., Debuc, E., Villie, P., Leclert, J., Marchand-arvier, J., Lescure, X., Jourdain, P.
Published in Med Mal Infect (2020)

Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early report

by Zylberberg, H, Benhamou, Y, Lagneaux, J, Landau, A, Chaix, M, Fontaine, H, Bochet, M, Poynard, T, Katlama, C, Pialoux, G, Brechot, C, Pol, S
Published 2000

Virological outcomes in ARV-naïve patients switching or not from a first successful boosted PI-regimen to efavirenz, nevirapine or abacavir regimens

by Bommenel, T, Meynard, JL, Launay, O, Simon, A, Mahamat, A, Martinez, V, Gilquin, J, Katlama, C, Lascaux, AS, Pradier, C, Rouveix, E, Costagliola, D, Abgrall, S
Published 2010

Upgraded Cobas Ampliprep-Cobas TaqMan Version 2.0 HIV-1 RNA Quantification Assay versus First Version: Correction of Underestimations

by Wirden, M., Tubiana, R., Fourati, S., Thevenin, M., Simon, A., Canestri, A., Ait-Arkoub, Z., Soulie, C., Marcelin, A. G., Katlama, C., Calvez, V.
Published 2011

Impact of Discrepancies between the Abbott RealTime and Cobas TaqMan Assays for Quantification of Human Immunodeficiency Virus Type 1 Group M Non-B Subtypes

by Wirden, M., Tubiana, R., Marguet, F., Leroy, I., Simon, A., Bonmarchand, M., Ait-Arkoub, Z., Murphy, R., Marcelin, A. G., Katlama, C., Calvez, V.
Published 2009

Activity of the integrase inhibitor S/GSK1349572 in subjects with HIV exhibiting raltegravir resistance: week 24 results of the VIKING study (ING112961)

by Eron, J, Livrozet, JM, Morlat, P, Lazzarin, A, Katlama, C, Hawkins, T, Fujiwara, T, Cuffe, R, Vavro, C, Santiago, J, Ait-Khaled, M, Min, S, Yeo, JM
Published 2010